Evidence map›Paper›PMID 31557780›Full record

ArticleMolecular genetics & genomic medicine2019

Association between APOE polymorphisms and lipid profile in Mexican Amerindian population.

José J Martínez-Magaña, Alma D Genis-Mendoza, Carlos A Tovilla-Zarate, Thelma B González-Castro, Isela Esther Juárez-Rojop, Yazmín Hernández-Díaz, Angélica G Martinez-Hernandez, Humberto Garcia-Ortíz, Lorena Orozco, María L López-Narvaez and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. International journal of general medicine · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Association betweenInternational journal of molecular sciences · 2022
    Article
  9. Review
  10. Genes · 2021
    Article
  11. Article
  12. Association ofSchizophrenia research. Cognition · 2021
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

José J Martínez-MagañaNational Institute of Genomic Medicine (Instituto Nacional de Medicina Genómica INMEGEN), Laboratory of Genomics of Psychiatric Diseases, Neurodegenerative and Addictions, Ministry of Health, Mexico City, Mexico.ORCID 0000-0003-0390-8252
Alma D Genis-MendozaNational Institute of Genomic Medicine (Instituto Nacional de Medicina Genómica INMEGEN), Laboratory of Genomics of Psychiatric Diseases, Neurodegenerative and Addictions, Ministry of Health, Mexico City, Mexico.ORCID 0000-0001-8180-477X
Carlos A Tovilla-ZarateComalcalco Multidisciplinary Academic Division, Autonomous Juárez University of Tabasco (Universidad Juárez Autónoma de Tabasco), Comalcalco, Tabasco, Mexico.ORCID 0000-0001-8170-8171
Thelma B González-CastroMultidisciplinary Academic Division of Jalpa de Méndez, Autonomous Juárez University of Tabasco (Universidad Juárez Autónoma de Tabasco), Jalpa de Méndez, Tabasco, Mexico.ORCID 0000-0001-8046-6908
Isela Esther Juárez-RojopAcademic Division of Health Sciences, Autonomous Juárez University of Tabasco (Universidad Juárez Autónoma de Tabasco), Villahermosa, Tabasco, Mexico.
Yazmín Hernández-DíazMultidisciplinary Academic Division of Jalpa de Méndez, Autonomous Juárez University of Tabasco (Universidad Juárez Autónoma de Tabasco), Jalpa de Méndez, Tabasco, Mexico.
Angélica G Martinez-HernandezNational Institute of Genomic Medicine (INMEGEN), Laboratory of Immunogenomics and Metabolic Diseases, Ministry of Health, Mexico City, Mexico.
Humberto Garcia-OrtízNational Institute of Genomic Medicine (INMEGEN), Laboratory of Immunogenomics and Metabolic Diseases, Ministry of Health, Mexico City, Mexico.
Lorena OrozcoNational Institute of Genomic Medicine (INMEGEN), Laboratory of Immunogenomics and Metabolic Diseases, Ministry of Health, Mexico City, Mexico.
María L López-NarvaezGeneral Hospital of Yajalon, Ministry of Health, Yajalon, Chiapas, Mexico.
Humberto NicoliniNational Institute of Genomic Medicine (Instituto Nacional de Medicina Genómica INMEGEN), Laboratory of Genomics of Psychiatric Diseases, Neurodegenerative and Addictions, Ministry of Health, Mexico City, Mexico.ORCID 0000-0003-2494-0067
National Institute of Genomic Medicine · MXUniversidad Juárez Autónoma de Tabasco · MXYalova University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundApolipoprotein E (ApoE) is a glycoprotein that plays an important role in lipid homeostasis at both cerebral and systemic levels. Moreover, the differential distribution of APOE gene alleles among different populations, means that ApoE isoforms could have different effects on lipids metabolism. The present study aims to evaluate the relationship between APOE gene alleles and the lipid profile in a Mexican Amerindian (MA) population.

methodsThis study included 1997 MA individuals of different ethnicities distributed throughout different states of Mexico. All individuals underwent anthropometric measurements as well as laboratory tests including fasting glucose (FG), total cholesterol (TC), triglycerides, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C). TaqMan

resultsAmong the biochemical variables analyzed, only the HDL-C and LDL-C levels showed statistical differences (p-value < .05) between individuals carrying different APOE alleles. For HDL-C, individuals carrying the E2 allele had higher HDL-C levels, followed by individuals carrying the E3 allele and carriers of the E4 allele presented the lowest levels of HDL-C (E2 > E3 > E4). This relationship was inversed for LDL-C levels (E2 < E3 < E4). Nevertheless, the difference of HDL-C levels between APOE-E3 and APOE-E4 carriers remained only in obese individuals.

conclusionsOur results suggest that APOE gene genotypes play an important role in the differential modulation of lipid profiles in the MA population with obesity.

Indexed as

Polymorphism, GeneticAdultAllelesApolipoproteins EBlack PeopleCholesterolCholesterol, HDLCholesterol, LDLFemaleGenotypeHumansIndians, Central AmericanLipidsMaleMexicoMiddle AgedApolipoproteins ECholesterolCholesterol, HDLCholesterol, LDLLipidsTriglyceridesAPOE genebody mass indexcholesterolMexican populationtriglyceride

Identifiers

PMID31557780
PMCPMC6825948
OpenAlexW2976113897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.